PRNP and prion disease: In the present study and based on our previous results [11], we assessed how the substitution of the GPI-SS of PrPC for that of Thy-1 influences the biology of the resulting chimeric PrPCGPIThy-1 in vivo, and how this impacts on the pathophysiology of prion disease.